Personalis, Inc. (PSNL)

USD 4.16

(7.77%)

Gross Profit Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual gross profit in 2023 was 18.2 Million USD , up 36.39% from previous year.
  • Personalis, Inc.'s latest quarterly gross profit in 2024 Q1 was 5.49 Million USD , up 5.53% from previous quarter.
  • Personalis, Inc. reported a annual gross profit of 13.35 Million USD in annual gross profit 2022, down -57.83% from previous year.
  • Personalis, Inc. reported a annual gross profit of 31.65 Million USD in annual gross profit 2021, up 57.39% from previous year.
  • Personalis, Inc. reported a quarterly gross profit of 5.49 Million USD for 2024 Q1, up 5.53% from previous quarter.
  • Personalis, Inc. reported a quarterly gross profit of 4.79 Million USD for 2023 Q2, up 1.31% from previous quarter.

Annual Gross Profit Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Gross Profit of Personalis, Inc. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 18.2 Million USD 36.39%
2022 13.35 Million USD -57.83%
2021 31.65 Million USD 57.39%
2020 20.11 Million USD -8.9%
2019 22.08 Million USD 87.04%
2018 11.8 Million USD 603.84%
2017 -2.34 Million USD 0.0%

Peer Gross Profit Comparison of Personalis, Inc.

Name Gross Profit Gross Profit Difference
Aclaris Therapeutics, Inc. 13.16 Million USD -38.275%
Biodesix, Inc. 36.07 Million USD 49.53%
bioAffinity Technologies, Inc. 791.61 Thousand USD -2200.108%
Castle Biosciences, Inc. 174.8 Million USD 89.584%
DarioHealth Corp. 5.98 Million USD -204.278%
Exact Sciences Corporation 1.84 Billion USD 99.013%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.169%
Illumina, Inc. 2.74 Billion USD 99.336%
Intelligent Bio Solutions Inc. 1.42 Million USD -1177.193%
iSpecimen Inc. 5.1 Million USD -256.466%
Standard BioTools Inc. 50.45 Million USD 63.909%
23andMe Holding Co. 99.37 Million USD 81.678%
Medpace Holdings, Inc. 524.5 Million USD 96.529%
NeoGenomics, Inc. 244.6 Million USD 92.556%
Inotiv, Inc. 165.44 Million USD 88.994%
Psychemedics Corporation 8.41 Million USD -116.427%
Prenetics Global Limited 8.82 Million USD -106.209%
Precipio, Inc. 6.01 Million USD -202.559%
RadNet, Inc. 93 Million USD 80.422%
Sotera Health Company 577.15 Million USD 96.845%
Star Equity Holdings, Inc. 11.92 Million USD -52.675%
Exagen Inc. 29.45 Million USD 38.186%
Natera, Inc. 492.74 Million USD 96.305%
Aspira Women's Health Inc. 5.26 Million USD -246.028%
Neogen Corporation 463.9 Million USD 96.075%
Myriad Genetics, Inc. 476.4 Million USD 96.178%
ICON Public Limited Company 1.81 Billion USD 98.996%
Bionano Genomics, Inc. 9.56 Million USD -90.341%
CareDx, Inc 178.32 Million USD 89.789%
Check-Cap Ltd. -212 Thousand USD 8688.679%
Twist Bioscience Corporation 133.34 Million USD 86.346%
Guardant Health, Inc. 336.89 Million USD 94.595%
BioNexus Gene Lab Corp. 1.32 Million USD -1269.539%
Fulgent Genetics, Inc. 104.45 Million USD 82.569%
Sera Prognostics, Inc. 96 Thousand USD -18866.667%
OPKO Health, Inc. 318.12 Million USD 94.276%
Applied DNA Sciences, Inc. 5.53 Million USD -229.054%
Star Equity Holdings, Inc. 11.92 Million USD -52.675%
MDxHealth SA 43.92 Million USD 58.551%
Prenetics Global Limited 8.82 Million USD -106.209%
ENDRA Life Sciences Inc. -275.45 Thousand USD 6710.25%
Mainz Biomed B.V. 509.65 Thousand USD -3472.585%
Trinity Biotech plc 19.45 Million USD 6.386%
Neuronetics, Inc. 51.7 Million USD 64.785%
bioAffinity Technologies, Inc. 791.61 Thousand USD -2200.108%